BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 11932392)

  • 1. Fusion-defective gibbon ape leukemia virus vectors can be rescued by homologous but not heterologous soluble envelope proteins.
    Farrell KB; Ting YT; Eiden MV
    J Virol; 2002 May; 76(9):4267-74. PubMed ID: 11932392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of envelope determinants of feline leukemia virus subgroup B that permit infection and gene transfer to cells expressing human Pit1 or Pit2.
    Sugai J; Eiden M; Anderson MM; Van Hoeven N; Meiering CD; Overbaugh J
    J Virol; 2001 Aug; 75(15):6841-9. PubMed ID: 11435563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variable regions A and B in the envelope glycoproteins of feline leukemia virus subgroup B and amphotropic murine leukemia virus interact with discrete receptor domains.
    Tailor CS; Kabat D
    J Virol; 1997 Dec; 71(12):9383-91. PubMed ID: 9371598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simian sarcoma-associated virus fails to infect Chinese hamster cells despite the presence of functional gibbon ape leukemia virus receptors.
    Ting YT; Wilson CA; Farrell KB; Chaudry GJ; Eiden MV
    J Virol; 1998 Dec; 72(12):9453-8. PubMed ID: 9811678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specificity in receptor usage by T-cell-tropic feline leukemia viruses: implications for the in vivo tropism of immunodeficiency-inducing variants.
    Lauring AS; Anderson MM; Overbaugh J
    J Virol; 2001 Oct; 75(19):8888-98. PubMed ID: 11533152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chimeras of receptors for gibbon ape leukemia virus/feline leukemia virus B and amphotropic murine leukemia virus reveal different modes of receptor recognition by retrovirus.
    Pedersen L; Johann SV; van Zeijl M; Pedersen FS; O'Hara B
    J Virol; 1995 Apr; 69(4):2401-5. PubMed ID: 7884886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three distinct envelope domains, variably present in subgroup B feline leukemia virus recombinants, mediate Pit1 and Pit2 receptor recognition.
    Boomer S; Eiden M; Burns CC; Overbaugh J
    J Virol; 1997 Nov; 71(11):8116-23. PubMed ID: 9343161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reassessing the role of region A in Pit1-mediated viral entry.
    Farrell KB; Russ JL; Murthy RK; Eiden MV
    J Virol; 2002 Aug; 76(15):7683-93. PubMed ID: 12097582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissection of gammaretroviral receptor function by using type III phosphate transporters as models.
    Farrell KB; Eiden MV
    J Virol; 2005 Jul; 79(14):9332-6. PubMed ID: 15994829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1.
    Stitz J; Buchholz CJ; Engelstädter M; Uckert W; Bloemer U; Schmitt I; Cichutek K
    Virology; 2000 Jul; 273(1):16-20. PubMed ID: 10891403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A hyperfusogenic gibbon ape leukemia envelope glycoprotein: targeting of a cytotoxic gene by ligand display.
    Fielding AK; Chapel-Fernandes S; Chadwick MP; Bullough FJ; Cosset FL; Russell SJ
    Hum Gene Ther; 2000 Apr; 11(6):817-26. PubMed ID: 10779159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational analysis of the proposed gibbon ape leukemia virus binding site in Pit1 suggests that other regions are important for infection.
    Chaudry GJ; Eiden MV
    J Virol; 1997 Oct; 71(10):8078-81. PubMed ID: 9311908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional complementation of a model target to study Vpu sensitivity.
    Janaka SK; Faurot J; Johnson MC
    PLoS One; 2013; 8(6):e68507. PubMed ID: 23840857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feline leukemia virus envelope sequences that affect T-cell tropism and syncytium formation are not part of known receptor-binding domains.
    Gwynn SR; Hankenson FC; Lauring AS; Rohn JL; Overbaugh J
    J Virol; 2000 Jul; 74(13):5754-61. PubMed ID: 10846053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequences in the cytoplasmic tail of the gibbon ape leukemia virus envelope protein that prevent its incorporation into lentivirus vectors.
    Christodoulopoulos I; Cannon PM
    J Virol; 2001 May; 75(9):4129-38. PubMed ID: 11287562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of a replication-competent retroviral vector for expression of the VSV-G envelope glycoprotein for cancer gene therapy.
    Jin SY; Jung YT
    Arch Virol; 2020 May; 165(5):1089-1097. PubMed ID: 32146506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of retroviral vectors based on the gibbon ape leukemia virus.
    Eglitis MA; Schneiderman RD; Rice PM; Eiden MV
    Gene Ther; 1995 Sep; 2(7):486-92. PubMed ID: 7584127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primate gammaretroviruses require an ancillary factor not required for murine gammaretroviruses to infect BHK cells.
    Xu W; Eiden MV
    J Virol; 2011 Apr; 85(7):3498-506. PubMed ID: 21270153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudotyping incompatibility between HIV-1 and gibbon ape leukemia virus Env is modulated by Vpu.
    Lucas TM; Lyddon TD; Cannon PM; Johnson MC
    J Virol; 2010 Mar; 84(6):2666-74. PubMed ID: 20042505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of specificity of cell-surface protease targeting of a cytotoxic hyperfusogenic gibbon ape leukaemia virus envelope glycoprotein.
    Kirkham LA; Bateman AR; Melcher AA; Vile RG; Fielding AK
    J Gene Med; 2002; 4(6):592-600. PubMed ID: 12439851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.